Semaglutide B 3.0 mg/ml PDS290
NOK0024 / Z2023097
Approved small_molecule active
Quick answer
Semaglutide B 3.0 mg/ml PDS290 for obesity is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- obesity
- Phase
- Approved
- Modality
- small_molecule
- Status
- active